This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mcmaster University. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Innovations by Rajanish Giri
Introduction
Rajanish Giri is a notable inventor based in Telliarganj Allahabad, India. He has made significant contributions to the field of biotechnology, particularly in the development of novel T cell engineering techniques. With a total of 4 patents to his name, Giri is recognized for his innovative approaches to enhancing immune responses.
Latest Patents
One of Giri's latest patents is titled "Trifunctional T cell-antigen coupler and methods and uses thereof." This invention describes a trifunctional molecule that includes a target-specific ligand, a ligand that binds a protein associated with the T cell receptor (TCR) complex, and a T cell receptor signaling domain polypeptide. The engineering of T cells with this novel receptor facilitates antigen-specific activation of various T cell functions, including cytokine production, degranulation, and cytolysis. This advancement holds promise for improving therapeutic strategies in immunology.
Career Highlights
Rajanish Giri is affiliated with McMaster University, where he continues to pursue his research and development efforts. His work focuses on enhancing the efficacy of T cell responses, which is crucial for advancing cancer immunotherapy and other medical applications.
Collaborations
Giri collaborates with esteemed colleagues, including Jonathan Lorne Bramson and Christopher W Helsen. These partnerships contribute to the innovative research environment at McMaster University, fostering advancements in the field of biotechnology.
Conclusion
Rajanish Giri's contributions to T cell engineering and his innovative patents reflect his commitment to advancing medical science. His work has the potential to significantly impact therapeutic approaches in immunology and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile